ArticleNature immunology2022
Author Correction: The immunoregulatory landscape of human tuberculosis granulomas.
Abstract readPublished Erratum
In one paragraph
Article in Nature immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- 3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy.Advanced healthcare materials · 2025Article
- Immune Responses in Lung Granulomas during Mtb/HIV Co-Infection: Implications for Pathogenesis and Therapy.Pathogens (Basel, Switzerland) · 2023Review
- Dynamic CD8Cell · 2023Article
Corrections and comments
- Erratum for
Authors and funding
28 authors.
Erin F McCaffreyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-7241-1798
Michele DonatoDepartment of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9968-6027
Leeat KerenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Zhenghao ChenCalico Life Sciences LLC, South San Francisco, CA, USA.
Alea DelmastroDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7959-3165
Megan B FitzpatrickDepartment of Pathology, University of Wisconsin, Madison, WI, USA.ORCID http://orcid.org/0000-0001-7040-8018
Sanjana GuptaDepartment of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.
Noah F GreenwaldDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7836-4379
Alex BaranskiDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
William GrafDivision of Biology and Bioengineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-4264-9479
Rashmi KumarDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Marc BosseDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Christine Camacho FullawayDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-4924-591X
Pratista K RamdialAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Erna ForgóDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Vladimir JojicCalico Life Sciences LLC, South San Francisco, CA, USA.
David Van ValenDivision of Biology and Bioengineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0001-7534-7621
Smriti MehraTexas Biomedical Research Institute, San Antonio, TX, USA.
Shabaana A KhaderDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-9545-4982
Sean C BendallDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1341-2453
Matt van de RijnDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Daniel KalmanDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Deepak KaushalSouthwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.ORCID http://orcid.org/0000-0003-3521-1257
Robert L HunterDepartment of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX, USA.
Niaz BanaeiDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Adrie J C SteynAfrica Health Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Purvesh KhatriDepartment of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-4143-4708
Michael AngeloDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mangelo0@stanford.edu.ORCID http://orcid.org/0000-0003-1531-5067
Funding
The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7MMOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0MEmory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Cheryl Liane Day · 2022 to 2026
$5.8MGiant MagnetoResistive (GMR) Sensors for Measuring Influenza VaccineR01AI125197 · NIAID · STANFORD UNIVERSITY · PI UTZ, PAUL JOSEPH, WANG, SHAN X. · 2016 to 2021
$5.0MHydrogen Sulfide and Tuberculosis DiseaseR01AI134810 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2018 to 2021
$2.2MMETABOLIC REPROGRAMMING OF T CELL ENERGY METABOLISM IN TUBERCULOSIS AND HIVR33AI138280 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2020 to 2023
$2.0MPredicting response to anti-PD-1 therapy in triple negative breast cancer by comprehensive profiling of the tumor microenvironmentF31CA246880 · NCI · STANFORD UNIVERSITY · PI GREENWALD, NOAH · 2020 to 2021
$53kNCI NIH HHS F31 CA246880NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI125197NIAID NIH HHS R01 AI134810NIAID NIH HHS R33 AI138280NIAID NIH HHS T32 AI007290NIH HHS P51 OD011133Wellcome Trust
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.